Literature DB >> 22177839

Interactions of vimentin- or desmin-expressing liver cells with N-acetylglucosamine-bearing polymers.

Sun-Jung Kim1, Hirohiko Ise, Mitsuaki Goto, Toshihiro Akaike.   

Abstract

It is necessary to develop highly functionalized liver cell culture systems for liver tissue engineering such as bioartificial livers and liver cell chips. To maintain a high level of hepatocyte function, well-organized patterning culture systems of hepatocytes and nonparenchymal cells would be advantageous. To design the patterning culture system using these cells, cell-recognizable polymers should be useful to regulate not only the hepatocytes, but also the nonparenchymal cells. Here, we report that N-acetylglucosamine (GlcNAc)-bearing polymers are useful as nonparenchymal cell-recognizable polymers. It has previously been reported that mesenchymal cells adhered to GlcNAc-bearing polymer-coated dishes through surface vimentin. It was also observed that nonparenchymal cells expressing vimentin or desmin specifically adhered to GlcNAc-bearing polymer-coated dishes. Especially, in hepatic stellate cells (HSCs) cultured on GlcNAc-bearing polymer-coated dishes, the expression of α-smooth muscle actin as an activated HSCs marker was suppressed in long-term. Therefore, HSCs were shown to maintain a quiescent state on PVGlcNAc-coated dishes during a long-term culture. These results demonstrated that GlcNAc-bearing polymers could be beneficial to culture nonparenchymal cells such as HSCs. Our findings suggest that galactose- and GlcNAc-bearing polymers can regulate the culture of all liver cells and may be useful tools for the establishment of liver tissue engineering.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22177839     DOI: 10.1016/j.biomaterials.2011.11.084

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  7 in total

1.  A hybrid substratum for primary hepatocyte culture that enhances hepatic functionality with low serum dependency.

Authors:  Qingyuan Meng; Chunsheng Tao; Zhiye Qiu; Toshihiro Akaike; Fuzhai Cui; Xiumei Wang
Journal:  Int J Nanomedicine       Date:  2015-03-23

2.  Desmin- and vimentin-mediated hepatic stellate cell-targeting radiotracer 99mTc-GlcNAc-PEI for liver fibrosis imaging with SPECT.

Authors:  Deliang Zhang; Rongqiang Zhuang; Zhide Guo; Mengna Gao; Lumei Huang; Linyi You; Pu Zhang; Jindian Li; Xinhui Su; Hua Wu; Xiaoyuan Chen; Xianzhong Zhang
Journal:  Theranostics       Date:  2018-02-02       Impact factor: 11.556

3.  Site-specific glycosylation regulates the form and function of the intermediate filament cytoskeleton.

Authors:  Heather J Tarbet; Lee Dolat; Timothy J Smith; Brett M Condon; E Timothy O'Brien; Raphael H Valdivia; Michael Boyce
Journal:  Elife       Date:  2018-03-07       Impact factor: 8.140

Review 4.  PET/SPECT Molecular Probes for the Diagnosis and Staging of Nonalcoholic Fatty Liver Disease.

Authors:  Tuo Shao; Lee Josephson; Steven H Liang
Journal:  Mol Imaging       Date:  2019 Jan-Dec       Impact factor: 4.488

5.  An AC electrothermal self-circulating system with a minimalist process to construct a biomimetic liver lobule model for drug testing.

Authors:  Shengli Mi; Baihan Li; Xiaoman Yi; Yuanyuan Xu; Zhichang Du; Shuaitao Yang; Wei Li; Wei Sun
Journal:  RSC Adv       Date:  2018-11-01       Impact factor: 4.036

6.  Senolytic treatment reduces cell senescence and necroptosis in Sod1 knockout mice that is associated with reduced inflammation and hepatocellular carcinoma.

Authors:  Nidheesh Thadathil; Ramasamy Selvarani; Sabira Mohammed; Evan H Nicklas; Albert L Tran; Maria Kamal; Wenyi Luo; Jacob L Brown; Marcus M Lawrence; Agnieszka K Borowik; Benjamin F Miller; Holly Van Remmen; Arlan Richardson; Sathyaseelan S Deepa
Journal:  Aging Cell       Date:  2022-07-23       Impact factor: 11.005

7.  Targeting activated hepatic stellate cells (aHSCs) for liver fibrosis imaging.

Authors:  Dan Li; Li He; Huizhuang Guo; Hanwei Chen; Hong Shan
Journal:  EJNMMI Res       Date:  2015-12-09       Impact factor: 3.138

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.